Instead, talk to your healthcare provider or pharmacist about next steps
The review traced the developmental history of GLP-1 research from the identification of the proglucagon gene in 1982 through to the contemporary landscape of GLP-1-based therapeutics across obesity, cardiovascular disease, NAFLD, neurodegeneration, and cancer biology
Furthermore, it reduces the risk of bone fracture and enhances cognition
The patent ultimately lapsed permanently due to non-payment of the 2019 maintenance fee
These small changes can reduce the kind of binge eating that contributes to weight gain, while also minimizing semaglutide side effects like nausea and constipation
FDA approval means a medication can be prescribed for that indication